GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modalis Therapeutics Corp (TSE:4883) » Definitions » Book Value per Share

Modalis Therapeutics (TSE:4883) Book Value per Share : 円28.21 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Modalis Therapeutics Book Value per Share?

Modalis Therapeutics's book value per share for the quarter that ended in Jun. 2024 was 円28.21.

During the past 12 months, Modalis Therapeutics's average Book Value Per Share Growth Rate was -64.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -42.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Modalis Therapeutics was 63.10% per year. The lowest was -42.50% per year. And the median was -13.20% per year.

Modalis Therapeutics's current price is 円86.00. Its book value per share for the quarter that ended in Jun. 2024 was 円28.21. Hence, today's PB Ratio of Modalis Therapeutics is 3.05.

During the past 6 years, the highest P/B Ratio of Modalis Therapeutics was 21.38. The lowest was 0.63. And the median was 2.50.

Warning Sign:

Modalis Therapeutics Corp stock PB Ratio (=3.19) is close to 3-year high of 3.32.


Modalis Therapeutics Book Value per Share Historical Data

The historical data trend for Modalis Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modalis Therapeutics Book Value per Share Chart

Modalis Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial 153.09 217.66 191.57 100.17 41.39

Modalis Therapeutics Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.20 62.66 41.39 29.59 28.21

Competitive Comparison of Modalis Therapeutics's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Modalis Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modalis Therapeutics's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modalis Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Modalis Therapeutics's PB Ratio falls into.


;
;

Modalis Therapeutics Book Value per Share Calculation

Modalis Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,380.42-0.00)/33.36
=41.39

Modalis Therapeutics's Book Value Per Share for the quarter that ended in Jun. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1,112.73-0.00)/39.44
=28.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Modalis Therapeutics  (TSE:4883) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Modalis Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of Modalis Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Modalis Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
16-5 Nihombashi-Kabuto-cho, Chuo-ku, Tokyo, JPN, 103-0026
Modalis Therapeutics Corp is a drug development company. It is engaged in research and development of Gene Therapy using core platform technology, non-editing CRISPR technology (CRISPR-GNDM). The company's products in pipeline are MDL-201, MDL-202, MDL-204, MDL-205, MDL-206, MDL-101, and MDL-102.

Modalis Therapeutics Headlines

No Headlines